On the contrary, coatomer protein complex subunit zeta 1 (COPZ1) was identified as a promising target for glioblastoma treatment, involving iron metabolism as a critical component of the COPZ1/NCOA4/FTH1 axis, manifesting a negative regulation of expression and activity of NCOA4. This evidence concerns the gene NCOA4 and glioblastoma.